Hi, Thank you some super useful points here. Will look at some of the BBRSC reports. I know about NC3R and think it is a good approach.
Only point I disagree with:
In terms of having a minister for dual use research this seems quite high cost to ask for, and low worth think Piers Millet suggestion of liaison officer more useful.
To clarify this is not a new Minister but adding this area of responsibility to a Ministerial portfolio so not at all a high cost ask (although ideally would do so in legislation which would be higher cost).
I think this is needed as however capable the civil service is at coordination there needs to be a Minister who is interested and held accountable in order to drive change and maintain momentum.
Sorry I misread point about minister, I agree that ministerial input as well, would be helpful. Also my take is that setting up a UK Nc3R type group may be harder than seems. As after 2015 concerns from dual use research, many countries set ‘centre for biosecurities’ that regulate dual use research eg. France and Denmark. However in the UK, life sciences funding bodies were keen to self regulate rather than set up something similar. So I suspect may not support as could quite credibly argue that they have been effective at regulating dual use research themselves.
Hi, Thank you some super useful points here. Will look at some of the BBRSC reports. I know about NC3R and think it is a good approach.
Only point I disagree with:
To clarify this is not a new Minister but adding this area of responsibility to a Ministerial portfolio so not at all a high cost ask (although ideally would do so in legislation which would be higher cost).
I think this is needed as however capable the civil service is at coordination there needs to be a Minister who is interested and held accountable in order to drive change and maintain momentum.
Sorry I misread point about minister, I agree that ministerial input as well, would be helpful. Also my take is that setting up a UK Nc3R type group may be harder than seems. As after 2015 concerns from dual use research, many countries set ‘centre for biosecurities’ that regulate dual use research eg. France and Denmark. However in the UK, life sciences funding bodies were keen to self regulate rather than set up something similar. So I suspect may not support as could quite credibly argue that they have been effective at regulating dual use research themselves.